| dc.contributor.advisor | 馮震宇<br>郭維裕 | zh_TW |
| dc.contributor.advisor | Fong, Jerry G.<br>Kuo, Wei-Yu | en_US |
| dc.contributor.author (Authors) | 雍海 | zh_TW |
| dc.contributor.author (Authors) | Yong, Hai | en_US |
| dc.creator (作者) | 雍海 | zh_TW |
| dc.creator (作者) | Yong, Hai | en_US |
| dc.date (日期) | 2023 | en_US |
| dc.date.accessioned | 1-Sep-2023 15:12:35 (UTC+8) | - |
| dc.date.available | 1-Sep-2023 15:12:35 (UTC+8) | - |
| dc.date.issued (上傳時間) | 1-Sep-2023 15:12:35 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0110932168 | en_US |
| dc.identifier.uri (URI) | http://nccur.lib.nccu.edu.tw/handle/140.119/146976 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 經營管理碩士學程(EMBA) | zh_TW |
| dc.description (描述) | 110932168 | zh_TW |
| dc.description.abstract (摘要) | 再生醫療（Regenerative Medicine）是一個醫學領域，它運用生物學、工程學和材料科學等跨學科的方法和技術，旨在恢復、替代或增強受損或缺失的組織和器官的功能。再生醫療的目標是利用細胞治療、組織工程、生物材料、生物活性因子等方法，促進身體自身的再生能力，以實現組織和器官的自我修復或替代。再生醫療的應用範圍非常廣泛，涵蓋了傷口癒合、組織再生、器官移植、心臟血管疾病治療、神經系統疾病治療等領域。它代表了一種革命性的醫學方法，有望改變傳統醫學對於組織損傷和器官功能缺失的治療方式，並提供更有效和持久的治療選擇。本研究從再生醫療的基本定義、特性與範疇入手，全面介紹了再生醫療全球的發展歷程，包括關鍵技術與應用的里程碑；然後回到台灣再生醫療的市場與發展，相關生技醫療企業面臨的挑戰與困難以及相關立法的進展；最後以三顧公司為例，研究探討電子公司轉型為再生醫療公司的艱難旅程，如何在艱難的產業環境下求生存求發展？是否可以作為其他公司在本產業發展的借鏡？ | zh_TW |
| dc.description.abstract (摘要) | Regenerative Medicine (再生醫療) is a medical field that utilizes interdisciplinary approaches and technologies such as biology, engineering, and materials science to restore, replace, or enhance the function of damaged or missing tissues and organs. The goal of regenerative medicine is to harness the body`s own regenerative capabilities through methods such as cell therapy, tissue engineering, biomaterials, and bioactive factors to achieve self-repair or replacement of tissues and organs.The applications of regenerative medicine are wide-ranging and include wound healing, tissue regeneration, organ transplantation, treatment of cardiovascular diseases, and neurological disorders, among others. It represents a revolutionary approach to medicine that has the potential to transform traditional treatments for tissue damage and organ dysfunction, providing more effective and long-lasting therapeutic options.This study provides a comprehensive overview of the global development of regenerative medicine, starting with its basic definition, characteristics, and scope. It highlights key milestones in the development of critical technologies and applications. The study then focuses on the market and development of regenerative medicine in Taiwan, as well as the progress in related legislation. Finally, using the case of MetaTech Corporation as an example, the study examines the challenging journey of an electronics company transitioning into a regenerative medicine company. How to survive and develop in a difficult industrial environment? Can it be served as a valuable reference for other companies seeking to enter this industry? | en_US |
| dc.description.tableofcontents | 第一章 緒論 .............................................................. 1第一節 研究動機 ........................................................ 2第二節 研究目的 ........................................................ 3第三節 研究方法 ........................................................ 4第二章 再生醫療產業概述 .................................................. 6第一節 再生醫療定義、特性與範疇 ........................................ 6第二節 再生醫療發展歷程 ................................................ 9第三節 再生醫療技術與應用領域 ......................................... 12第四節 再生醫療產業的價值鏈與相關利害關係者 ........................... 14第五節 再生醫療市場分析 ............................................... 15第三章 台灣再生醫療發展 ................................................. 23第一節 台灣再生醫療的發展 ............................................. 23第二節 台灣再生醫療的市場 ............................................. 24第三節 台灣再生醫療的法規 ............................................. 26第四章 三顧個案分析 ..................................................... 36第一節 轉型背景 ....................................................... 37第二節 技術發展 ....................................................... 39第三節 業務發展 ....................................................... 51第四節 市場拓展 ....................................................... 55第五節 智財分析 ....................................................... 58第五章 結論與建議 ....................................................... 66第一節 結論 ........................................................... 66第二節 建議 ........................................................... 68參考文獻 ................................................................ 72 | zh_TW |
| dc.format.extent | 6024498 bytes | - |
| dc.format.mimetype | application/pdf | - |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0110932168 | en_US |
| dc.subject (關鍵詞) | 再生醫療 | zh_TW |
| dc.subject (關鍵詞) | 細胞治療 | zh_TW |
| dc.subject (關鍵詞) | 幹細胞 | zh_TW |
| dc.subject (關鍵詞) | 幹細胞移植 | zh_TW |
| dc.subject (關鍵詞) | 器官 | zh_TW |
| dc.subject (關鍵詞) | 組織工程 | zh_TW |
| dc.subject (關鍵詞) | 自我修復 | zh_TW |
| dc.subject (關鍵詞) | 人工器官 | zh_TW |
| dc.subject (關鍵詞) | 組織再生 | zh_TW |
| dc.subject (關鍵詞) | Regenerative Medicine | en_US |
| dc.subject (關鍵詞) | Cell Therapy | en_US |
| dc.subject (關鍵詞) | Stem Cell | en_US |
| dc.subject (關鍵詞) | Stem Cell Transplantation | en_US |
| dc.subject (關鍵詞) | Organ | en_US |
| dc.subject (關鍵詞) | Tissue Engineering | en_US |
| dc.subject (關鍵詞) | Self-healing | en_US |
| dc.subject (關鍵詞) | Artificial Organs | en_US |
| dc.subject (關鍵詞) | Tissue Regeneration | en_US |
| dc.title (題名) | 再生醫療產業之發展與市場分析 － 以三顧公司轉型為例 | zh_TW |
| dc.title (題名) | Development and Market Analysis of the Regenerative Medicine Industry - A Case Study of MetaTech`s Transformation | en_US |
| dc.type (資料類型) | thesis | en_US |
| dc.relation.reference (參考文獻) | 1. 台灣經濟部 - 2022 生技產業白皮書 Biotechology Industry in Taiwanhttps://www.biopharm.org.tw/images/2022/2022Biotechnology-Industry-inTaiwan.pdf2. 再生醫學聯盟 (ARM：Allance for Regenerative Medicine) - 《2021 年的再生醫學：創造第一和記錄的一年》3. Deloitte 勤業眾信 - 《2022 年生命科技產業展望 |大規模數位化：兌現科學的承諾》4. pwc 資誠 - 《全球生技製藥趨勢：再生醫學躍為醫療新主流》5. KPMG Taiwan - 再生醫療三法及生技醫藥條例的制度實益與產業影響https://kpmg.com/tw/zh/home/insights/2022/02/2022-kpmg-insight/act-forthe-development-of-biotech-and-new-pharmaceuticals-industry-and-itsinfluence.html6. 台灣衛生福利部 https://www.mohw.gov.tw/mp-1.html7. 台灣衛生福利部食品藥物管理署 https://www.fda.gov.tw/TC/index.aspx8. 台灣衛生福利部醫事司 https://dep.mohw.gov.tw/DOMA/mp-106.html9. 台灣立法院議事及發言系統 https://lis.ly.gov.tw/lylgmeetc/lgmeetkm10. KPMG - 再生醫療三法及生技醫藥條例的制度實益與產業影響https://kpmg.com/tw/zh/home/insights/2022/02/2022-kpmg-insight/act-forthe-development-of-biotech-and-new-pharmaceuticals-industry-and-itsinfluence.html11. Yahoo！新聞 - 再生醫療雙法是什麼？爭議有哪些？立法進度又到哪了？ | zh_TW |
